肺动脉高压药物治疗的新进展被引量：1

New progress in the drug treatment of pulmonary arterial hypertension

导出

摘要肺动脉高压（pulmonary arterial hypertension,PAH）是一种渐进性疾病,其特点为肺血管重塑,导致肺动脉压增高和右心室衰竭。近年来随着人们对 PAH 发病机制认识地不断提高,针对 PAH发病各环节的治疗均取得了长足进展,从而改变了 PAH 患者的命运。 Pulmonary arterial hypertension is a progressive disease characterized by pulmonary vascular remodeling,which may lead to increased pulmonary artery pressure and right ventricular heart failure.With the increasing understanding of the pathogenesis of PAH in recent years,considerable progress has been made for the treatment of various aspects of PAH,and the fate of PAH patients has been changed.

作者王凯玲任涛

机构地区同济大学附属东方医院呼吸科

出处《国际呼吸杂志》 2015年第10期796-800,共5页 International Journal of Respiration

关键词肺动脉高压药物治疗 Pulmonary arterial hypertension Drug treatment

分类号 R544.1 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献2

1Barst RJ,Langleben D,Badesch D,菅鑫妍.使用选择性内皮素A受体拮抗剂sitaxsentan治疗肺动脉高压[J].中国处方药,2006,5(8):29-29. 被引量：38
2无.肺动脉高压筛查诊断与治疗专家共识[J].中华心血管病杂志,2007,35(11):979-987. 被引量：273

二级参考文献31

1荆志成,徐希奇.肺动脉高压现代分类和诊断策略[J].中华心血管病杂志,2004,32(12):1160-1162. 被引量：40
2荆志成.六分钟步行距离试验的临床应用[J].中华心血管病杂志,2006,34(4):381-384. 被引量：98
3Proceeding of 3rd World Symposium on Pulmonary Arterial Hypertension. Venice, Italy, June 23-25, 2003. J Am Coll Cardiol, 2004,43(2 Suppl S) : 1S-90S.
4Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest, 2004, 126( Suppl 1 ) : 1 S-92S.
5Galie N, Torbicki A, Barst A, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J, 2004,25 ( 24 ) : 2243-2278.
6Barst RJ, McGoon M, Torbicki A,et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol, 2004,43( 12 Suppl S) :40S-47S.
7Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol, 2004,43 (12) :5S-12S.
8Pietra GG, Capron F, Stewart S, et al. Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol, 2004,43(12 Suppl S) :25S-32S.
9McGoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension : ACCP evidence-based clinical practice guidelines. Chest, 2004,126 (1 Suppl): 14S-34S.
10Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med, 2006,173 (9) :1023-1030.